A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours
NCT04882176
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class
Stopped
Not meeting expected endpoints
Conditions
Advanced Tumours
Interventions
DRUG:
LM-061
Sponsor
LaNova Medicines Limited